Table 2

Availability of insulin (any brand or company) in the private-sector market in Delhi state, India (N=40 pharmacy outlets)

Insulin type	Molecule description	Strength (IU/mL)	Per cent availability (number of pharmacy outlets)
Human insulin	Soluble insulin	40*	47.5% (19)
	Soluble insulin	100	12.5% (5)
	Isophane insulin	40*	25.0% (10)
	Isophane insulin	100	5.0% (2)
	Biphasic isophane insulin: 30% soluble insulin 70% isophane insulin	40*	67.5% (27)
		100*	37.5% (15)
	Biphasic isophane insulin: 50% soluble insulin 50% isophane insulin	40	20.0% (8)
		100	5.0% (2)
Mean availability of any human insulins listed on 2013 Delhi essential medicine list			44.4%
Analogue insulin	Insulin aspart	100*	12.5% (5)
	Biphasic insulin aspart: 30% insulin aspart and 70% protamine crystallised aspart	100	15.0% (6)
	Biphasic insulin aspart: 50% insulin aspart and 50% protamine crystallised aspart	100	2.5% (1)
	Insulin glargine	100*	25.0% (10)
	Insulin glulisine	100*	5.0% (2)
	Insulin lispro	100*	10.0% (4)
	Insulin lispro biphasic injection: 25% insulin lispro 75% lispro protamine	100	12.5% (5)
	Insulin lispro biphasic injection: 50% insulin lispro 50% lispro protamine	100	12.5% (5)
Mean availability of any analogue insulin listed on 2013 Delhi essential medicine list			13.1%